Disclosure Policy: SIDM requires planners, speakers, faculty, and all those who influence the content of this CME activity to disclose any financial relationships they have with commercial interests that are relevant to the activity. The disclosures were reviewed for any conflict of interest and subject to a mechanism for resolution of conflict of interest. This statement of relevant financial relationships is being presented to the audience in their attendance documents prior to the activities.
The remainder of the faculty, abstract/poster presenters, and planning committee have no relevant disclosures.
All relevant financial relationships have been mitigated.
Mark Graber, a speaker, disclosed stock options from RecoverX and Curai; consulting fees from Leapfrog Group and NORC.
David Koch, a speaker, disclosed consulting fees from Saladax Biomedical and an honorarium from Roche Diagnostics.
Ann Marie Kumfer, a speaker, disclosed an honorarium from Human Diagnosis Project.
Andrew Olson, a speaker, disclosed grant support from 3M.
Collin Stultz, a speaker, disclosed stock in UnlearnAI and BloomerTech; salary from Apple Computers and Bristol Myers Squibb.
Thilan Wijesekera, a planning committee member/moderator/poster presenter, disclosed consultation fees from National Board of Medical Examiners.
Andrew Zimolzak, a speaker, disclosed common stock held in Stryker Corp.